Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

401–425 of 832 articles for Checkpoints

Then save them, add them to a collection or cite them together.
  1. Perspective · 24 Jun 2021

    Immunotheraphy

    British Biomedical Bulletin · Volume 9, Issue 3

    suppressor mechanisms must be reduced by producing a tumour killing environment and regulating immunological checkpoints. Immunotherapy appears to work better in cancers that are more immunogenic. In 1970, bladder…

  2. Perspective · 18 May 2021

    Short note on cancer immunotherapy

    Clinical Investigation · Volume 11, Issue 5

    suppressor mechanisms must be lowered by creating a tumor-killing environment and modulating immunological checkpoints. Immunotherapy appears to work better in more immunogenic tumors. Bladder cancer was the initial…

  3. Case report · 26 Feb 2021

    Durable Response of a Recurrent, Irresectable, Locally Advanced, Microsatellite Instable Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated with Cetuximab

    Dermatology Case Reports · Volume 6, Issue 1

    this subgroup, biologicals that target for example the immune-suppressed microenvironment (e.g. the immune checkpoint inhibitors cemiplimab and pembrolizumab) or dysregulated tumorigenic pathways (e.g. the chimeric…

  4. Case report · 20 Oct 2020

    Sequential Decitabine and Carboplatin Induced Stabilisation of Tumour Burden in a Patient with Immunotherapy-Resistant Metastatic Melanoma

    Clinical Oncology: Case Reports · Volume 3, Issue 5

    progress in the treatment of metastatic melanoma in recent years with targeted and immune checkpoint inhibitor therapy, there is no effective treatment option once resistance to all of these treatments ... priming…

  5. Editorial · 27 Jul 2020

    MARKET ANALYSIS OF CANCER THERAPEUTIC RESEARCH

    Cancer Surgery · Volume 5, Issue 2

    everywhere, with several treatments approved for various cancer types, including CAR T-cells, immune checkpoint inhibitors and more in development such as tumor infiltrating lymphocyte (TIL) therapy. TILs successfully…

  6. Conference abstract · 7 Mar 2019

    Optimization of EGFR-based targeted therapy and beyond

    while INFγ induces the expression of programmed death ligand-1 (PD-L1), an immune checkpoint receptor ligand, contributing to cetuximab resistance through an immune escape mechanism. We have recently demonstrated

  7. Editorial · 2019

    Immunotherapy

    Cancer Surgery · Volume 4, Issue 2

    everywhere, with several treatments approved for various cancer types, including CAR T-cells, immune checkpoint inhibitors and more in development such as tumor infiltrating lymphocyte (TIL) therapy. TILs successfully…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels